" class="no-js "lang="en-US"> Howard Hughes Medical Institute - Medtech Alert
  • Home
  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions
Sunday, September 21, 2025

Light/Dark

  • News
    • Artificial Intelligence
    • Clinical Trials
    • Drug Development
    • Equipment
    • Gene Therapy
    • Health Apps
    • Manufacturing
    • Regulatory
    • Smart Labs
    • Supply Chain
  • Medtech TV
  • Industry News
    • Appointments
    • Fundraising
    • Mergers & Aquisitions
    • Partnerships
  • Diseases
    • Cardiovascular
    • COVID-19
    • Immunology
    • Infectious Diseases
    • Oncology
    • Respiratory
  • Resources
    • Companies
    • People
    • White Papers
  • News
    • Artificial Intelligence
    • Clinical Trials
    • Drug Development
    • Equipment
    • Gene Therapy
    • Health Apps
    • Manufacturing
    • Regulatory
    • Smart Labs
    • Supply Chain
  • Medtech TV
  • Industry News
    • Appointments
    • Fundraising
    • Mergers & Aquisitions
    • Partnerships
  • Diseases
    • Cardiovascular
    • COVID-19
    • Immunology
    • Infectious Diseases
    • Oncology
    • Respiratory
  • Resources
    • Companies
    • People
    • White Papers

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Home » Companies » Howard Hughes Medical Institute

Howard Hughes Medical Institute | Pharmtech Focus

Howard Hughes Medical Institute

About Howard Hughes Medical Institute

Howard Hughes Medical Institute

HHMI is a science philanthropy whose mission is to advance basic biomedical research and science education for the benefit of humanity.

The vision for the Howard Hughes Medical Institute (HHMI) began to coalesce in the late 1940s among a small group of physicians and scientists advising the aviator and industrialist Howard R. Hughes.

Related Story

Companies

Researchers Discover New Model for "Global" DNA Repair | Pharmtech Focus

Researchers Discover New Model for "Global" DNA Repair

March 31 2022

Two studies provide a radically new picture of how bacterial cells continually repair damaged sections […]

Join Our Newsletter.

Subscribe to receive email updates from Medtech Alert.

By signing up, I agree to receive emails from Medtech Alert and to the Privacy Policy and Terms of Use.

Copyright © 2022 Advertainment Media All Rights Reserved.

Medtech Alert report on the latest Medical and Pharmaceutical technology news, bringing you up to the minute stories and features to stay ahead. Industry professionals and decision makers turn to us to keep up with and shape their industry.

For Media, Press and Advertising Enquiries please use our contact form or email address:


Contact

Email

Advertainment Media Ltd.
Pantiles Chambers
85 High Street
Tunbridge Wells
TN1 1XP

  • Home
  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions